Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
11
2019
Text Message Platform Dismissed From TCPA Class Action Because It Was Not the “Maker or Initiator” of Text Message Womble Bond Dickinson (US) LLP
Oct
11
2019
U.S. Immigration and the Growing Marijuana Industry Jackson Lewis P.C.
Oct
11
2019
Overlapping Provisions in Major Healthcare Bills 2019 McDermott Will & Emery
Oct
11
2019
BRAG Biobased Products Blog: October 11, 2019 Bergeson & Campbell, P.C.
Oct
11
2019
OSI v. Apotex – Christmas in October! Schwegman, Lundberg & Woessner, P.A.
Oct
11
2019
Do You Want Fries With That? Mintz
Oct
11
2019
Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements Keller and Heckman LLP
Oct
11
2019
Cannabis Consumer Class Actions: The Implicit and Indispensable Ascertainability Requirement Carlton Fields
Oct
11
2019
EUON Publishes Nanopinion on Strengthening Societal Engagement with Nanotechnologies Bergeson & Campbell, P.C.
Oct
10
2019
EPA Updates Aquatic Life Benchmarks for Several Pesticides Bergeson & Campbell, P.C.
Oct
10
2019
Collateral Estoppel Does Not Attach To PTAB Invalidity Determination Pending Appeal Mintz
Oct
10
2019
Opioid Update: Sixth Circuit Won’t Halt Bellwether Trial (and more) Squire Patton Boggs (US) LLP
Oct
10
2019
Antitrust Surprises from DOJ during the Trump Administration – Predicting the Consequences Foley & Lardner LLP
Oct
10
2019
Will the Eleventh Circuit Fall in Line with its Sister Circuits in Interpreting Spokeo’s Standing Requirements in FACTA Cases? Bilzin Sumberg
Oct
10
2019
Table for Two, Please: D.C. Department of Employment Services Issues Revised Guidance on Calculating Overtime Wages for Non-Exempt Employees Working Multiple Positions Mintz
Oct
10
2019
California Chamber of Commerce Challenges Proposition 65 Warnings for Acrylamide Keller and Heckman LLP
Oct
9
2019
FDA’s Approach to New Packaging Factor Database Explained at KH Seminar Keller and Heckman LLP
Oct
9
2019
California’s Proposition 12 Challenged on Constitutional Grounds Keller and Heckman LLP
Oct
9
2019
ECHA Urges Companies to Get Ready for New REACH Requirements for Nanomaterials Bergeson & Campbell, P.C.
Oct
9
2019
OEHHA Proposes Modifications to Prop 65 Retail Seller Responsibilities Bergeson & Campbell, P.C.
Oct
8
2019
FDA Publishes List of Records Required Under FSVP Keller and Heckman LLP
Oct
7
2019
CMS Passes Final Rule Reducing Regulations Burdensome on Health Care Providers Robinson & Cole LLP
Oct
7
2019
U.S. Set To Impose Retaliatory Tariffs On $7.5 Billion In EU Goods Following WTO’s Airbus Ruling Barnes & Thornburg LLP
Oct
7
2019
Restaurant Employers Take Note: DOL Proposes New FLSA Tip Regulations Barnes & Thornburg LLP
Oct
7
2019
FDA Releases Chapter 14: Recall Plans in the Latest Installment to the Agency’s Multi-Chapter Draft Guidance on the Human HARPC Rule Keller and Heckman LLP
Oct
6
2019
FTC Courtesy Warnings to CBD Marketers About Unsubstantiated Claims Likely Drawing to an End Hinch Newman LLP
Oct
5
2019
New Connecticut Law Requires Policy on Opioid Antagonists at Colleges, Universities Jackson Lewis P.C.
Oct
4
2019
McDermottPlus Check-up: October 4, 2019 McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins